Low choline concentrations in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans
- PMID: 17698533
- PMCID: PMC7977665
- DOI: 10.3174/ajnr.A0580
Low choline concentrations in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans
Abstract
Background and purpose: Spectroscopic studies (1H-MR spectroscopy) of normal-appearing white matter (NAWM) in patients with multiple sclerosis (MS) with MR imaging brain lesions have already been performed, but our intention was to investigate NAWM in MS patients who lack brain lesions to elucidate whether the same pathologic changes could be identified.
Materials and methods: We checked 350 medical files of patients with MS who are registered in our institution. Fourteen patients (11 women and 3 men; mean age, 48.6 years; handicap score, Expanded Disability Status Scale [EDSS] 2.9; range, 1-6.5) with clinically definite MS and a normal MR imaging of the brain were included. 1H-MR spectroscopy was performed in 4 voxels (size approximately 17x17x17 mm3) using absolute quantification of metabolite concentrations. Fourteen healthy control subjects (11 women and 3 men; mean age, 43.3 years) were analyzed in the same way.
Results: Significant differences in absolute metabolite concentrations were observed, with the patients with MS showing a lower total concentration of N-acetyl compounds (tNA), including N-acetylaspartate and N-acetyl aspartylglutamate (13.5 mmol/L versus 14.6 mmol/L; P=.002) compared with the healthy control subjects. Unexpectedly, patients with MS presented significantly lower choline-containing compounds (Cho) compared with healthy control subjects (2.2 mmol/L versus 2.4 mmol/L; P<.001). The EDSS showed a positive correlation to myo-inositol concentrations (0.14 mmol/L per EDSS; r2=0.06) and a negative correlation to tNA concentrations (-0.41 mmol/L per EDSS; r2=0.22).
Conclusion: The unexpected finding of lower Cho concentrations has not been reported previously. We suggest that patients with MS who lack lesions in the brain constitute a separate entity and may have increased protective or healing abilities.
Figures


Similar articles
-
High field MR imaging and 1H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis: correlation between metabolic alterations and diagnostic MR imaging criteria.J Neurol. 2008 Jan;255(1):56-63. doi: 10.1007/s00415-007-0666-9. Epub 2007 Dec 20. J Neurol. 2008. PMID: 18080854 Clinical Trial.
-
Axonal damage but no increased glial cell activity in the normal-appearing white matter of patients with clinically isolated syndromes suggestive of multiple sclerosis using high-field magnetic resonance spectroscopy.AJNR Am J Neuroradiol. 2007 Sep;28(8):1517-22. doi: 10.3174/ajnr.A0594. AJNR Am J Neuroradiol. 2007. PMID: 17846203 Free PMC article.
-
Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.PLoS One. 2013 Apr 17;8(4):e61817. doi: 10.1371/journal.pone.0061817. Print 2013. PLoS One. 2013. PMID: 23613944 Free PMC article.
-
[Magnetic resonance spectroscopy and its clinical applications in multiple sclerosis].Nihon Rinsho. 2003 Aug;61(8):1435-41. Nihon Rinsho. 2003. PMID: 12962035 Review. Japanese.
-
Proton magnetic resonance spectroscopy in multiple sclerosis.Neuroimaging Clin N Am. 2009 Feb;19(1):45-58. doi: 10.1016/j.nic.2008.08.002. Neuroimaging Clin N Am. 2009. PMID: 19064199 Free PMC article. Review.
Cited by
-
Early metabolic alterations in the normal‑appearing grey and white matter of patients with clinically isolated syndrome suggestive of multiple sclerosis: A proton MR spectroscopic study.Exp Ther Med. 2023 May 30;26(1):349. doi: 10.3892/etm.2023.12048. eCollection 2023 Jul. Exp Ther Med. 2023. PMID: 37324507 Free PMC article.
-
Functional Connectivity and Metabolic Alterations in Medial Prefrontal Cortex in a Rat Model of Fetal Alcohol Spectrum Disorder: A Resting-State Functional Magnetic Resonance Imaging and in vivo Proton Magnetic Resonance Spectroscopy Study.Dev Neurosci. 2019;41(1-2):67-78. doi: 10.1159/000499183. Epub 2019 Apr 18. Dev Neurosci. 2019. PMID: 30999297 Free PMC article.
-
Short-term cuprizone feeding verifies N-acetylaspartate quantification as a marker of neurodegeneration.J Mol Neurosci. 2015 Mar;55(3):733-48. doi: 10.1007/s12031-014-0412-6. Epub 2014 Sep 5. J Mol Neurosci. 2015. PMID: 25189319
-
Quantifying the Metabolic Signature of Multiple Sclerosis by in vivo Proton Magnetic Resonance Spectroscopy: Current Challenges and Future Outlook in the Translation From Proton Signal to Diagnostic Biomarker.Front Neurol. 2019 Nov 15;10:1173. doi: 10.3389/fneur.2019.01173. eCollection 2019. Front Neurol. 2019. PMID: 31803127 Free PMC article. Review.
-
A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis.Brain. 2008 Nov;131(Pt 11):3092-102. doi: 10.1093/brain/awn190. Epub 2008 Sep 4. Brain. 2008. PMID: 18772223 Free PMC article.
References
-
- Compston A, Coles A. Multiple sclerosis. Lancet 2002;359:1221–31 - PubMed
-
- Kapeller P, McLean MA, Griffin CM, et al. Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study. J Neurol 2001;248:131–38 - PubMed
-
- McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121–27 - PubMed
-
- Larsson HB. Magnetic resonance imaging and spectroscopy. Acta Neurol Scand 1995;91:(suppl 159):36 - PubMed
-
- Filippi M, Grossman RI. MRI techniques to monitor MS evolution: the present and the future. Neurology 2002;58:1147–53 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical